QihanBio is a China-based biotechnology company that researches and develops genome-editing cell therapies for the treatment of cancer... Read more
QihanBio is a China-based biotechnology company that researches and develops genome-editing cell therapies for the treatment of cancer... Read more
News
Dec 19, 2025
Clinical Trials Arena
Qihan Biotech: Qihan Biotech begins subject dosing in Phase I/IIa study of QT-019B for rSLE
Jun 25, 2025
StreetInsider
Press Release: Qihan Biotech : iPSC-CAR-NK Cell Therapy Clinical Result Published in Cell, Marking a Global Breakthrough in Autoimmune Disease Treatment
May 14, 2025
StreetInsider
Press Release: Qihan Biotech : Qihan Biotech Presented its Breakthrough CAR-T Research at ASGCT 2025
Jun 18, 2024
Business Wire
Press Release: Qihan Biotech : Qihan Biotech Announces Publication in Microbiology Spectrum on CRISPR-Cas Multiplexed Genome Editing for Reducing African Swine Fever Virus
Sep 26, 2023
Asian Venture Capital Journal
Qihan Biotech: Matrix, HongShan back China's Qihan Biotech
Sep 25, 2023
ChinaBio Today
Qihan Biotech: Qihan Biotech Raises $16 Million for Gene-Edited Stem Cell Products
Jul 20, 2023
ChinaBio Today
Qihan Biotech: Qihan Starts Trial of Gene-Edited iPSC-Derived NK Cell Therapy for Leukemia
Oct 17, 2022
Yahoo
Qihan Biotech: Qihan Biotech Appoints Tony W. Ho to its Board of Directors
Apr 08, 2022
FirstWord Pharma
Qihan Biotech: Qihan Biotechnology Presents Preclinical Data at American Association for Cancer Research Annual Meeting 2022
Mar 31, 2021
Volanews
Qihan Biotech: China's Qihan Biotech Nets $67M Funding From LAV, Sequoia, And Others
Qihan Biotech Competitors
1
2
3
4
5
6
7
8
9
10